DK0888289T3 - Antikonvulsive, enantiomore aminosyrederivater - Google Patents

Antikonvulsive, enantiomore aminosyrederivater

Info

Publication number
DK0888289T3
DK0888289T3 DK97916897T DK97916897T DK0888289T3 DK 0888289 T3 DK0888289 T3 DK 0888289T3 DK 97916897 T DK97916897 T DK 97916897T DK 97916897 T DK97916897 T DK 97916897T DK 0888289 T3 DK0888289 T3 DK 0888289T3
Authority
DK
Denmark
Prior art keywords
anticonvulsant
enantiomore
amino acid
acid derivatives
animal
Prior art date
Application number
DK97916897T
Other languages
Danish (da)
English (en)
Inventor
Harold Kohn
Original Assignee
Res Corp Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21760388&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0888289(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Res Corp Technologies Inc filed Critical Res Corp Technologies Inc
Application granted granted Critical
Publication of DK0888289T3 publication Critical patent/DK0888289T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK97916897T 1996-03-15 1997-03-17 Antikonvulsive, enantiomore aminosyrederivater DK0888289T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1352296P 1996-03-15 1996-03-15
PCT/US1997/004579 WO1997033861A1 (en) 1996-03-15 1997-03-17 Anticonvulsant enantiomeric amino acid derivatives

Publications (1)

Publication Number Publication Date
DK0888289T3 true DK0888289T3 (da) 2001-09-03

Family

ID=21760388

Family Applications (2)

Application Number Title Priority Date Filing Date
DK97916897T DK0888289T3 (da) 1996-03-15 1997-03-17 Antikonvulsive, enantiomore aminosyrederivater
DK00109377T DK1038522T3 (da) 1996-03-15 1997-03-17 Antikonvulsive enantiomere aminosyrederivater

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK00109377T DK1038522T3 (da) 1996-03-15 1997-03-17 Antikonvulsive enantiomere aminosyrederivater

Country Status (12)

Country Link
EP (2) EP0888289B1 (de)
JP (1) JP3145414B2 (de)
AT (2) ATE268169T1 (de)
AU (1) AU718577B2 (de)
CA (1) CA2248317C (de)
DE (3) DE122009000010I2 (de)
DK (2) DK0888289T3 (de)
ES (2) ES2157567T3 (de)
FR (1) FR09C0006I2 (de)
NL (1) NL300376I1 (de)
PT (2) PT1038522E (de)
WO (1) WO1997033861A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048899A (en) * 1997-03-17 2000-04-11 Research Corporation Tech., Inc. Anticonvulsant enantiomeric amino acid derivatives
EP1642889A1 (de) * 2004-10-02 2006-04-05 Schwarz Pharma Ag Verbessertes Syntheseschema für Lacosamid
EP1873527A1 (de) 2006-06-30 2008-01-02 Schwarz Pharma Ag Verfahren zur Identifizierung von CRMP-Modulatoren
US8093426B2 (en) * 2007-12-04 2012-01-10 Ranbaxy Laboratories Limited Intermediate compounds and their use in preparation of lacosamide
DE102008059155A1 (de) 2008-11-27 2010-06-02 Ratiopharm Gmbh Trockenverarbeitung und neue Formen von Lacosamid
EP2462107A1 (de) 2009-08-06 2012-06-13 Medichem, S.A. Feste formen eines n-(phenylmethyl)propanamid-derivats und herstellungsverfahren dafür
US8853439B2 (en) * 2009-09-25 2014-10-07 Cadila Healthcare Limited Processes for the preparation of lacosamide and intermediates thereof
IT1398044B1 (it) * 2010-01-29 2013-02-07 Archimica Srl Processo per la preparazione della lacosamide
KR20120128667A (ko) 2010-02-08 2012-11-27 낫코 파마 리미티드 라코사미드의 제조방법
WO2011099033A1 (en) * 2010-02-09 2011-08-18 Msn Laboratories Limited Process for preparing (r)-2-acetamido-n-benzyl-3-methoxy-propionamide
EP2399901A1 (de) 2010-06-23 2011-12-28 Archimica GmbH Zwischenprodukt zur Herstellung von Lacosamid und Verfahren zu dessen Herstellung und Umwandlung zu Lacosamid
EP2621893A1 (de) 2010-10-01 2013-08-07 UCB Pharma GmbH Verfahren zur herstellung von aminosäurederivaten
US9226971B2 (en) 2010-10-15 2016-01-05 Nektar Therapeutics N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides
PL2444390T3 (pl) 2010-10-19 2017-06-30 Euticals Gmbh Sposób wytwarzania Lakozamidu
EP2468261A1 (de) 2010-12-02 2012-06-27 UCB Pharma GmbH Formulierung von Lacosamid
EP2645997B1 (de) 2010-12-02 2022-08-10 UCB Pharma GmbH Einmal-täglich-formulierung von lacosamid
CN104771356A (zh) * 2014-01-09 2015-07-15 山东方明药业集团股份有限公司 一种拉科酰胺注射液及其制备方法
US11278634B1 (en) 2021-02-12 2022-03-22 Extrovis Ag Stable parenteral composition of lacosamide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378729A (en) * 1985-02-15 1995-01-03 Research Corporation Technologies, Inc. Amino acid derivative anticonvulsant
DK173553B1 (da) * 1985-02-15 2001-03-12 Res Corp Technologies Inc Aminosyrederivater, antikonvulsant præparat som indeholder aminosyrederivat samt anvendelse af aminosyrederivater til frems

Also Published As

Publication number Publication date
DE122009000010I1 (de) 2009-05-20
JP3145414B2 (ja) 2001-03-12
DE122009000010I2 (de) 2010-10-21
CA2248317C (en) 2003-12-02
EP0888289A1 (de) 1999-01-07
ES2157567T3 (es) 2001-08-16
EP1038522B1 (de) 2004-06-02
DE69705210D1 (de) 2001-07-19
DE69729392D1 (de) 2004-07-08
NL300376I1 (nl) 2009-05-06
ES2218024T3 (es) 2004-11-16
PT888289E (pt) 2001-09-28
JP2000505476A (ja) 2000-05-09
DE69729392T2 (de) 2005-06-02
ATE202079T1 (de) 2001-06-15
DE69705210T2 (de) 2001-09-20
DK1038522T3 (da) 2004-10-11
EP1038522A3 (de) 2003-01-15
WO1997033861A1 (en) 1997-09-18
AU718577B2 (en) 2000-04-13
EP0888289B1 (de) 2001-06-13
FR09C0006I2 (fr) 2009-12-18
CA2248317A1 (en) 1997-09-18
ATE268169T1 (de) 2004-06-15
FR09C0006I1 (de) 2009-04-17
EP1038522A2 (de) 2000-09-27
PT1038522E (pt) 2004-10-29
AU2539497A (en) 1997-10-01

Similar Documents

Publication Publication Date Title
NL300376I1 (nl) Enantiomere anticonvulsieaminozuurderivaten
DK0616807T3 (da) Benzimidazol anvendelig i behandlingen af forstyrrelser i centralnervesystemet
PT1004578E (pt) Derivados hidroxamida do acido 5-oxo-pirrolidino-2-carboxilico
BR9808281A (pt) Compostos, composições farmacêuticas, processo para tratar doenças proliferativas e/ou distúrbios do sistema imune e para preparar um composto, e, uso de um composto
EA199900620A1 (ru) Фталазиноны
FI974447A (fi) Semikarbatsonit, joilla on keskushermostoaktiivisuutta, ja niitä sisältävät farmaseuttiset valmisteet
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
ES552348A0 (es) Procedimiento de preparar agentes anticonvulsivos derivados de aminoacidos
ATE399545T1 (de) Mittel zur verringerung der eigeweidefette
DE69828197D1 (de) Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
ATE264104T1 (de) Immunmodulierende arzneimittelzusammenstellung
ES2148561T3 (es) Prevencion y curacion de enfermedades alergicas de tipo i.
ES2058085T3 (es) Composicion anticonvulsivante que contiene un derivado de aminoacido, y utilizacion de dicho derivado de aminoacido.
DK498889A (da) Substituerede aromatiske forbindelser med virkning paa centralnervesystemet
EP0978277A4 (de) Antirheumatische mittel
DE69123757T2 (de) Epoxysuccinamidsäurederivat
NO963791D0 (no) Peptidderivater
ES2171389T3 (es) Derivados anticonvulsivos de aminoacidos.
DE69827706D1 (de) 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems
PT88242A (pt) Processo para a preparacao de eteres e tioeteres tendo actividade terapeutica
BR9506763A (pt) Derivados de carbamoil metil uréia
DE69622393T2 (de) Neue verwendung von pyrazolopyridinverbindungen
EA200101043A1 (ru) Способ лечения неврологических или нейропсихиатрических расстройств